Announcements Trials
Browse Landscape

Status

No longer available 1

Sponsor Class

OTHER 1

Study Type

Expanded_access 1

Sponsor

Cancer Type

Sarcoma 1Other solid neoplasm 1Genitourinary 1Gastrointestinal 1CNS 1

Conditions

Medulloblastoma 2Wilms Tumor 1Sarcoma, Ewing 1Rhabdomyosarcoma 1Rhabdoid Tumor 1Retinoblastoma 1Pinealoma 1Neuroectodermal Tumors, Primitive 1Neuroblastoma 1Meningeal Neoplasms 1Hepatoblastoma 1Ependymoma 1

Interventions

Cyclophosphamide 4Automobiles 3fludarabine 2etoposide phosphate 2Nivolumab 2Etoposide 2Celecoxib 2tozuleristide 1perillyl alcohol 1omburtamab I-131 1Watchful Waiting 1Vincristine 1Thiotepa 1Temozolomide 1Tamoxifen 1Sirolimus 1Proton Therapy 1ONC206 1Mesna 1Isotretinoin 1Immunotherapy 1Hydrocortisone 1Granulocyte Colony-Stimulating Factor 1Filgrastim 1Cisplatin 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Pinealoma × omburtamab I-131 × 1 year × Clear all
NCT05064306 2025-08-01

131I-omburtamab for the Treatment of Central Nervous System/Leptomeningeal Neoplasms in Children and Young Adults

Memorial Sloan Kettering Cancer Center

No longer available
CNSGastrointestinalGenitourinaryOther solid neoplasmSarcoma

Medulloblastoma, Meningeal Neoplasms, Wilms Tumor, Neuroblastoma, Pinealoma, Retinoblastoma, Rhabdomyosarcoma, Sarcoma, Ewing, Hepatoblastoma, Neuroectodermal Tumors, Primitive, Rhabdoid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡